PT - JOURNAL ARTICLE AU - Adilia Warris TI - Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim? AID - 10.1183/20734735.0056-2021 DP - 2021 Sep 01 TA - Breathe PG - 210056 VI - 17 IP - 3 4099 - http://breathe.ersjournals.com/content/17/3/210056.short 4100 - http://breathe.ersjournals.com/content/17/3/210056.full SO - Breathe2021 Sep 01; 17 AB - Macrolides should not be used as first-line therapy for community-acquired pneumonia in children as no clinical benefit is shown and widespread use is associated with an emerging increase in macrolide resistance amongst S. pneumoniae and M. pneumoniae https://bit.ly/3yQuedF